Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 9/20 | 0.33 |
| ▸ | PPARA | Q07869 | 9/20 | 0.33 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31581569 | 0.94 | PPARD (0.32) | PPARDPPARAPPARGPOLBAPEX1 | |
| SCHEMBL25361650 | 0.93 | PPARD (0.31) | PPARDPPARAPPARG | |
| SCHEMBL2970031 | 0.92 | — | — | |
| SCHEMBL26942625 | 0.92 | POLB (0.30) | POLBAPEX1 | |
| SCHEMBL2968070 | 0.90 | GAA (0.32) | POLBAPEX1 | |
| SCHEMBL25352357 | 0.89 | PPARG (0.30) | PPARDPPARAPPARG | |
| SCHEMBL25405330 | 0.88 | PPARD (0.31) | PPARDPPARA | |
| SCHEMBL7547124 | 0.88 | CYP1A2 (0.33) | PPARDPPARAPPARGPOLBAPEX1 | |
| SCHEMBL30704867 | 0.86 | GAA (0.36) | POLBAPEX1 | |
| SCHEMBL27559360 | 0.86 | GAA (0.36) | POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4289824-A1 | URACIL COMPOUND CONTAINING CARBOXYLATE FRAGMENT AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE | Jiangsu Flag Chemical Industry Co., Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |
| EP-4230621-A1 | SUBSTITUTED N-BENZOIC ACID URACILS, THEIR SALTS AND USE OF SAID COMPOUNDS AS HERBICIDAL AGENTS | Bayer AG (DE) | 2023-08-23 | — | — | EP | disclosed |
| US-7767624-B2 | 3-Heterocyclyl substituted benzoic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| EP-1527052-B1 | 3-HETEROCYCLYL SUBSTITUTED BENZOIC ACID DERIVATIVES | BASF AG (DE) | 2006-05-31 | — | — | EP | disclosed |
| US-20050239655-A1 | 3-heterocyclyl substituted benzoic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239655-A1 | 3-heterocyclyl substituted benzoic acid derivatives | DDT, CBR3, BROX | PPARD 469/4885PPARA 1370/4885PPARG 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.